Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Reducing AZT intake
Feb 7, 2005

Dr Pierone, Thanks for your reply. My doctor advised that I could switch to Abacavir but she also mentioned that a number of patients have suffered the hypersensitivity you mentioned and also Viread (She refered to it as Tenofovir) is not currently available in Thailand.

So looks like the lower dose of AZT it is,but she has asked me to do another viral load test in 2 months to keep a close eye on viral load levels.

Once again many thanks for the second opinion and I'll let you know how the lower dosage goes.

Response from Dr. Pierone

This sounds like a good plan in view of the geographic constraints. Lipoatrophy is typically a slow moving process in any case, so you should be fine, Good luck and let us know how things go.



Previous
nontreatable problems?
Next
total viral erradication.

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement